Here's some other vaccine news of note for the week:
> ClearPath and Astellas are teaming up to develop a Staphylococcus aureus vaccine. Release
> Novavax shares fell 22% as its updates this week in RSV and seasonal flu disappointed investors. Washington Business Journal article
> A Stanford team found a new way to combat Zika that could aid in drug and vaccine development. FierceBiotechResearch article
> PharmaJet and Invectys teamed up for a phase 2 study of cancer vaccine INVAC-1 using PharmaJet's needle-free vaccine technology. Release